DRUGS FOR LOCAL TRANSDERMAL USE IN TREATING PATIENTS WITH DORSALGIA

Abstract

The term «dorsopathy» now refers to pain syndromes in the back of of neurovisceral etiology related to degenerative spinal diseases.The most important type of dorsopathies is the back pain, which, according to WHO experts, at the end of the XX century became a non-communicable epidemic as it affects about 80 per cent of the population during life.Dorsalgia (DA) is an exceptionally common skeletal pain syndrome in the population. For the treatment of patients nonsteroid antiinflammatory drugs (NSAIDs) with express pain and anti-inflammatory effects are widely used. Their indication is often associated with the risk of side effects, which are increasing in older patients with polymorbidity requiring simultaneous administration of several drugs at the same time. An alternative to systemic use of NSAIDs may in some cases be the local use of transdermal forms of drugs. Consideration is being given to the use of Deep Relief and Deep Hit in patients with DA depending on the characteristics of the clinical pattern of the disease. Research findings on the bioavailability, efficiency and tolerability of drugs are presented.

Keywords

• dorsalgia
• dorsopathy
• back pain
• ibuprofen
• deep relief
• deep hit
• transdermal medicinal forms
• therapy
• nonsteroid antiinflammatory drugs